In the Boardroom
Refine Search
Pharmaceutical
Current Boehringer Ingelheim chief medical officer Christopher Corsico is to move to British drugmaker GlaxoSmithKline at the end of the year. 20 September 2018
Pharmaceutical
Swiss drugmaker Vifor Pharma today announced changes to its senior management team. 20 September 2018
Pharmaceutical
Canada’s Zymeworks, a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today named Anthony (Tony) Polverino, executive vice president of early development and chief scientific officer. 19 September 2018
Pharmaceutical
Sanofi today announced that it will change the organizational structure of two of its Global Business Units (GBU) to provide greater focus on its operations in mature markets and across emerging markets. 13 September 2018
Biotechnology
Based on its strong focus on the Asian market, French metabolic diseases biotech company Poxel has made another significant move to solidify its position, forming a fully-owned Japanese subsidiary, Poxel KK. 13 September 2018
Generics
A number of US hospitals are pressing ahead with plans to launch their own generics company, Civica Rx, with the appointment of Martin VanTrieste as chief executive. 11 September 2018
Pharmaceutical
Boehringer Ingelheim today announced that Dr Christopher Corsico, senior vice president, corporate division Medicine and chief medical officer, will be leaving the German family-owned pharma major to pursue his career outside of the company effective December 31, 2018. 11 September 2018
Pharmaceutical
Sweden-based Medivir today revealed it has appointed Linda Basse as Chief Medical Officer effective October 1, 2018. 10 September 2018
Pharmaceutical
Ironshore Pharmaceuticals, a wholly-owned subsidiary of Canada’s Highland Therapeutics, has appointed Scott Evangelista to the position of president and chief operating officer (COO). 7 September 2018
Biotechnology
Rheos Medicines, a Boston, USA, biotech developing novel medicines that modulate metabolic pathways in immune cells to treat disease, has poached an experienced big pharma R&D leader from Roche to be its new chief executive. 6 September 2018
Pharmaceutical
French drugmaker Ipsen has named Asad Mohsin Ali as general manager of its UK and Ireland affiliate. 4 September 2018
Pharmaceutical
London-listed Arix Bioscience has announced a change to its executive team which will see current chief executive Joe Anderson moved to the role of chief investment officer. 4 September 2018
Pharmaceutical
Switzerland-based Tillotts Pharma, part of the Japanese Zeria Group, has announced that Karima Boubekeur is joining the company to take on the newly-created role of global head of innovation. 3 September 2018
Generics
With effect from September 1, Peter Goldschmidt succeeded Claudio Albrecht as the chief executive of Stada Arzneimittel. 3 September 2018
Pharmaceutical
EMD Serono, the biopharmaceutical business of Merck KGaA in the USA and Canada, today announced that Rehan Verjee has been appointed president of EMD Serono and global head of innovative medicine franchises of Merck. 31 August 2018
Pharmaceutical
Indianapolis, USA-based Eli Lilly has announced that Anne White is to become president of Lilly Oncology and senior vice president of Lilly, effective September 1, 2018. 31 August 2018
Biotechnology
The senior vice president of US commercial operations at Amgen has left to join another US biotech major. 29 August 2018
Pharmaceutical
US pharma major Bristol-Myers Squibb yesterday announced that Christopher Boerner has been appointed executive vice president and chief commercial officer, effective immediately. 29 August 2018
Pharmaceutical
Vertex Pharmaceuticals today announced that Ludovic Fenaux has been appointed senior vice president, international commercial operations with responsibility for commercial activities outside of the USA and Canada, which includes overseeing offices and operations across Europe, Australia and Latin America. 23 August 2018
Biotechnology
Rare diseases specialist Swedish Orphan Biovitrum has appointed Anne Marie de Jonge Schuermans as head of its new Technical Operations organization, bringing together Sobi’s manufacturing operations/biological development and supply, quality, supply chain, procurement and environment and safety operations. 22 August 2018
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze